ABSTRACT
Psychotropics will only deliver the outcomes promised if the patient actually has been accurately identified as having a bona fide Diagnostic and Statistical Manual of Mental Disorders (DSM-5) anxiety disorder. The reader should appreciate the commonalities of the genetic heritability and brain functional abnormalities that appear to be common across the DSM-5 anxiety disorders and should also understand there may be significant symptom overlap. If the major depressive disorder (MDD) is premorbid and the anxiety only occurs while depressed, then the patient just carries the single MDD diagnosis and all anxiety falls under the rubric of the patient having psychomotor agitation. Each DSM-5 anxiety disorder will have essentially the same approach to guideline-based treatment. This anxiety is in excess to what the average person might experience or perceive, may be accompanied by physical symptoms, including panic attacks, that are triggered and expected to result from exposure to social situation. Many MDD patients are generally anxious, ruminate, or even obsess.
